HCRT and cancer: Given the role of HIF-1α in glucose metabolism and cancer progression, we investigated several levels of HIF-1α regulation in HepG2 cells stimulated with orexin A. Real-time PCR assays demonstrated that the mRNA level of HIF-1α was dose-dependently increased in response to orexin A treatment.